A patent strategy for genomic and research tool patents: are there any differences between the USA, Europe and Japan?
The patenting of genomics and research tools, and its effects on the development of therapeutics are attracting considerable attention. Regardless of whether one is in favor of patents for this technology, it is not specifically excluded from patenting in most countries. Accordingly, it is imperative that a suitable global patent strategy be developed and followed to maximize both intellectual property rights and returns on R&D investment.
L Ihnen J
Rothwell, Figg, Ernst & Manbeck, 555 Thirteenth Street NW, Suite 701-East, DC 20004, Washington, USA